Vaccine Center Recent Publications
Investigators and associated faculty at NYU Langone’s Vaccine Center publish the results of their research in leading journals. Read the latest papers to learn more about our work.
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US Adults
Clinical infectious diseases. 2024 Mar 27;
Plasmatic HIV-1 soluble gp120 is associated with correlates of immune dysfunction and inflammation in ART-treated individuals with undetectable viremia
Journal of infectious diseases. 2024 Mar 14; 229:763-774
Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants
Pediatrics (1948). 2024 Mar 01; 153:
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Nature communications. 2024 Feb 05; 15:1075
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
Journal of infectious diseases. 2023 Dec 20; 228:1662-1666
mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection
iScience. 2023 Dec 15; 26:?-?
Generation of quality-controlled SARS-CoV-2 variant stocks
Nature protocols. 2023 Dec ; 18:3821-3855
Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct epitopes
EBioMedicine. 2023 Dec ; 98:104875